Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1820704-26-4
24962-46-7
380426-70-0
24962-79-6
909854-52-0
379729-37-0
727717-65-9 | 1-(2-fluorobenzenesulfonyl)piperidine-4-carboxylic acid | AA019II4 | MFCD04619479
736949-15-8 | (2E)-2-Cyano-3-[1-(2-fluorophenyl)-2,5-dimethyl-1h-pyrrol-3-yl]acrylic acid | AA019IT4 | MFCD06655009
730950-96-6 | [(4-amino-3-ethyl-5-methylphenyl)sulfanyl]formonitrile | AA019J2T | MFCD00613378
790263-60-4 | 4-benzyl-5-[(pyrrolidin-1-yl)methyl]-4H-1,2,4-triazole-3-thiol | AA019JDM | MFCD06357397
436091-57-5 | 2-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]methyl}sulfanyl)acetic acid | AA019JNX | MFCD00096559
82068-14-2 | 3-Methyl-2-(thiophene-2-sulfonamido)butanoic acid | AA019JXN | MFCD03834403
1170415-79-8 | 3-chloro-N-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)propanamide | AA019K50 | MFCD11786652
31036-67-6 | 1-(3-aminophenyl)pyrrolidine-2,5-dione | AA019KAV | MFCD11052202
930889-25-1 | 3-Methyl-5-nitroisoxazolo[5,4-b]pyridine | AA019KGE | MFCD09347296
903708-97-4 | 1-(4-nitrophenyl)-3-(oxolan-2-ylmethyl)urea | AA019KLU | MFCD07044883
Journal: Bioorganic & medicinal chemistry letters20101101